Federation des caisses Desjardins du Quebec’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-4,500
Closed -$1.03K 2782
2024
Q4
$1.03K Hold
4,500
﹤0.01% 2320
2024
Q3
$9.68K Hold
4,500
﹤0.01% 1890
2024
Q2
$23.2K Hold
4,500
﹤0.01% 1575
2024
Q1
$24.1K Buy
+4,500
New +$31.1K ﹤0.01% 1590

Other funds holding SYRS

Federation des caisses Desjardins du Quebec's SYRS Position: Q1 2025 in Review

Federation des caisses Desjardins du Quebec sold out of Syros Pharmaceuticals, Inc. Common Stock (SYRS) in Q1 2025, closing a stake of 4,500 shares — an estimated $1.03K sold.

Federation des caisses Desjardins du Quebec first reported a position in SYRS in Q1 2024 and held it in 4 quarters. The position peaked at $24.1K in Q1 2024. 7 funds tracked by Wall St. Rank hold SYRS as of Q1 2025.

  • Federation des caisses Desjardins du Quebec reported no remaining Syros Pharmaceuticals, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Federation des caisses Desjardins du Quebec sold 4,500 Syros Pharmaceuticals, Inc. Common Stock shares in Q1 2025, an estimated $1.03K.
  • Federation des caisses Desjardins du Quebec first reported a position in Syros Pharmaceuticals, Inc. Common Stock in Q1 2024 and held it in 4 quarters.
  • Federation des caisses Desjardins du Quebec's Syros Pharmaceuticals, Inc. Common Stock position peaked at $24.1K in Q1 2024.
  • 7 funds tracked by Wall St. Rank held Syros Pharmaceuticals, Inc. Common Stock as of Q1 2025.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q1 2025, filed 15 May 2025.